1. Home
  2. TWO vs PCRX Comparison

TWO vs PCRX Comparison

Compare TWO & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Two Harbors Investment Corp

TWO

Two Harbors Investment Corp

HOLD

Current Price

$9.52

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$21.99

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWO
PCRX
Founded
2009
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
TWO
PCRX
Price
$9.52
$21.99
Analyst Decision
Hold
Strong Buy
Analyst Count
6
5
Target Price
$12.94
$37.60
AVG Volume (30 Days)
2.7M
756.7K
Earning Date
01-01-0001
05-15-2026
Dividend Yield
14.88%
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.16
Revenue
N/A
$541,533,000.00
Revenue This Year
N/A
$9.77
Revenue Next Year
N/A
$9.71
P/E Ratio
N/A
$137.06
Revenue Growth
N/A
26.04
52 Week Low
$8.84
$18.80
52 Week High
$14.17
$27.99

Technical Indicators

Market Signals
Indicator
TWO
PCRX
Relative Strength Index (RSI) 42.06 45.89
Support Level N/A $20.09
Resistance Level $10.25 $24.65
Average True Range (ATR) 0.48 1.11
MACD 0.00 -0.08
Stochastic Oscillator 36.87 37.21

Price Performance

Historical Comparison
TWO
PCRX

About TWO Two Harbors Investment Corp

Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. The majority of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: